TAM
TFG Asset Management Portfolio holdings
AUM
$554M
This Quarter Return
+8.94%
1 Year Return
+17.58%
3 Year Return
+43.97%
5 Year Return
+47.35%
10 Year Return
+63.64%
AUM
$554M
AUM Growth
+$554M
(+78%)
Cap. Flow
+$73.4M
Cap. Flow
% of AUM
13.25%
Top 10 Holdings %
Top 10 Hldgs %
84.43%
Holding
40
New
7
Increased
12
Reduced
4
Closed
3
Top Buys
| 1 |
UiPath
PATH
|
$61.1M |
| 2 |
Workiva
WK
|
$10.3M |
| 3 |
Scholar Rock
SRRK
|
$3.67M |
| 4 |
Tarsus Pharmaceuticals
TARS
|
$2.9M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
$2.05M |
Top Sells
| 1 |
Informatica
INFA
|
$14M |
| 2 |
Compañía de Minas Buenaventura
BVN
|
$867K |
| 3 |
OTLY
Oatly Group
OTLY
|
$798K |
| 4 |
Keros Therapeutics
KROS
|
$734K |
| 5 |
Cameco
CCJ
|
$150K |
Sector Composition
| 1 | Technology | 40.13% |
| 2 | Healthcare | 13.37% |
| 3 | Energy | 9.04% |
| 4 | Materials | 0.3% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $176M | 28.3% | 13,722,244 +4,772,244 | +53% | +$61.1M |
|
|
KGEI
2
Kolibri Global Energy
KGEI
$200M
| $48.7M | 7.84% | 7,068,857 -1,711 | -0% | -$11.8K |
|
|
AUTL
3
Autolus Therapeutics
AUTL
$399M
| $21.7M | 3.49% | 9,500,000 +900,000 | +10% | +$2.05M |
|
4
Sprinklr
CXM
$2.24B
| $18.6M | 3% | 2,200,000 | – | – |
|
5
Lyft
LYFT
$6.73B
| $15.8M | 2.54% | 1,000,000 | – | – |
|
|
6
Workiva
WK
$4.61B
| $10.3M | 1.65% | +150,000 | New | +$10.3M |
|
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $10.1M | 1.63% | 250,000 +71,530 | +40% | +$2.9M |
|
8
Annexon
ANNX
$226M
| $6.74M | 1.09% | 2,810,000 +160,000 | +6% | +$384K |
|
9
Celldex Therapeutics
CLDX
$1.47B
| $6.43M | 1.04% | 316,150 +55,150 | +21% | +$1.12M |
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $5.54M | 0.89% | 68,660 +5,518 | +9% | +$445K |
|
|
TECX
11
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $4.55M | 0.73% | 228,832 +41,332 | +22% | +$821K |
|
12
Axsome Therapeutics
AXSM
$6.05B
| $4.34M | 0.7% | 41,531 +7,725 | +23% | +$806K |
|
|
13
Scholar Rock
SRRK
$3.14B
| $3.67M | 0.59% | +103,482 | New | +$3.67M |
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.48M | 0.56% | 161,396 +54,396 | +51% | +$1.17M |
|
15
Pharvaris
PHVS
$1.39B
| $3.31M | 0.53% | 188,100 +61,105 | +48% | +$1.08M |
|
16
Relay Therapeutics
RLAY
$619M
| $2.42M | 0.39% | 699,000 +80,000 | +13% | +$277K |
|
17
Immunovant
IMVT
$2.56B
| $2.37M | 0.38% | 147,817 +16,650 | +13% | +$266K |
|
18
Snowflake
SNOW
$79.6B
| $2.24M | 0.36% | 10,000 | – | – |
|
|
19
Keros Therapeutics
KROS
$618M
| $1.71M | 0.28% | 128,000 -55,000 | -30% | -$734K |
|
|
20
Cameco
CCJ
$33.7B
| $1.43M | 0.23% | 19,280 -2,020 | -9% | -$150K |
|
21
Amylyx Pharmaceuticals
AMLX
$836M
| $1.4M | 0.23% | +218,750 | New | +$1.4M |
|
22
Dyne Therapeutics
DYN
$1.92B
| $1.32M | 0.21% | +138,375 | New | +$1.32M |
|
23
Hudbay
HBM
$4.75B
| $1.14M | 0.18% | 107,000 | – | – |
|
24
Alkermes
ALKS
$4.78B
| $447K | 0.07% | +15,632 | New | +$447K |
|
25
Sociedad Química y Minera de Chile
SQM
$13B
| $272K | 0.04% | +7,700 | New | +$272K |
|